Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck dB Balance Sheet — Total Assets ($M) ($M)
Postgres DB financial_values (via lib/db.py)
Latest, Q2 2026
129,802
Period ended Jun 30, 2026
Change on a year earlier
+10.4%
117,523 in Q2 2025
History
68 quarters
Since Q4 2008
Sources
66
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Balance Sheet — Total Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 129,802 | +10.4% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 128,685 | +11.8% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 136,866 | +16.9% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 129,546 | +10.2% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 117,523 | +4.3% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 115,122 | +8.8% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 117,106 | +9.8% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 117,532 | +10.1% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 112,630 | +7.8% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 105,849 | -1.8% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 106,675 | -2.3% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 106,727 | -0.3% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 104,469 | -2.5% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 107,796 | +1.1% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 109,160 | +3.3% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 107,081 | +14.5% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 107,095 | +18.1% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 106,668 | +17.4% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 105,694 | +15.4% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 93,494 | +4.1% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 90,688 | +0.1% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 90,847 | +7.0% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 91,588 | +8.5% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 89,800 | +7.8% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 90,615 | +7.9% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 84,913 | +3.1% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 84,397 | +2.1% | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 83,331 | -2.1% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 83,965 | -1.3% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 82,354 | -4.3% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 82,637 | -6.0% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 85,130 | -7.1% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 85,040 | -8.4% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 86,041 | -10.9% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 87,872 | -7.9% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 91,676 | -6.8% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 92,804 | -3.8% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 96,561 | -2.2% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 95,377 | -6.2% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 98,335 | -2.9% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 96,475 | -6.0% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 98,755 | -8.9% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 101,677 | +3.6% | SEC Filing ↗ |
| Q3 2015 | Sep 30, 2015 | 101,232 | -0.6% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 102,582 | +4.8% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 108,345 | -0.1% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 98,167 | -7.1% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2014 | Sep 30, 2014 | 101,808 | -4.3% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 97,860 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 108,460 | +2.1% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 105,645 | -0.5% | Form 10-K (filed 2014-02-27) ↗ |
| Q2 2013 | Sep 30, 2013 | 106,419 | +0.1% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 106,200 | +0.7% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 106,132 | +1.0% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 106,301 | -0.2% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 105,525 | -0.6% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 105,509 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 105,128 | -0.6% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 106,534 | -1.2% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2011 | Jun 30, 2011 | 106,195 | 0.0% | Form 10-Q (filed 2011-08-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 105,781 | -5.8% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 107,840 | +253.0% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 106,171 | +259.4% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2010 | Mar 31, 2010 | 111,594 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 112,314 | +138.0% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 30,547 | – | Form 10-Q (filed 2009-10-29) ↗ |
| Q2 2009 | Jun 30, 2009 | 29,545 | – | Form 10-Q (filed 2009-07-24) ↗ |
| Q4 2008 | Dec 31, 2008 | 47,196 | – | Form 10-K (filed 2010-03-01) ↗ |
Breakdown
What makes up db balance sheet — total assets ($m)
- Cash and Cash Equivalents ($M)6,849 · Q2 2026
- Short-Term Investments ($M)292 · Q2 2026
- Accounts Receivable, Net ($M)12,564 · Q2 2026
- Inventories ($M)6,207 · Q2 2026
- Other Current Assets ($M)10,767 · Q2 2026
- Total Current Assets ($M)36,679 · Q2 2026
- Property, Plant and Equipment (PP&E), Net ($M)25,737 · Q2 2026
- Goodwill ($M)21,582 · Q2 2026
- Other Intangibles, Net ($M)24,978 · Q2 2026
- Long-Term Investments ($M)1,222 · Q2 2026
- Other Noncurrent Assets ($M)19,604 · Q2 2026
- Trade Accounts Payable ($M)3,827 · Q2 2026
- Loans Payable and Current Portion of Long-Term Debt ($M)2,825 · Q2 2026
- Income Taxes Payable ($M)4,224 · Q2 2026
- Accrued and Other Current Liabilities ($M)14,725 · Q2 2026
- Total Current Liabilities ($M)27,731 · Q2 2026
- Long-Term Debt ($M)51,081 · Q2 2026
- Deferred Income Taxes ($M)1,433 · Q2 2026
- Other Noncurrent Liabilities ($M)7,573 · Q2 2026
- Common Stock ($M)1,788 · Q2 2026
- Other Paid-In Capital ($M)44,950 · Q2 2026
- Retained Earnings ($M)63,269 · Q2 2026
- Accumulated Other Comprehensive Loss ($M)-3,942 · Q2 2026
- Treasury Stock, at Cost ($M)-64,132 · Q2 2026
- Merck & Co., Inc. Stockholders' Equity ($M)41,933 · Q2 2026
- Noncontrolling Interests ($M)51 · Q2 2026
- Total Equity ($M)41,984 · Q2 2026
Cite this data
StockData. (2026). Merck DB Balance Sheet — Total Assets ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_assets
See every metric in the Merck KPI table. Data updated Oct 26, 2026.